American Journal of Epidemiology Vol. 136, No. 3: 296-307
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the Elderly
1Currently at Medstat Systems Inc. Ann Arbor, Ml
2Department of Epidemiology, School of Public Health, University of Michigan Ann Arbor, Ml
Reprint requests to Dr. Arnold S Monto, Department of Epidemiology, School of Public Health I, University of Michigan, 109 Observatory, Ann Arbor, Ml 48109-2029
During the winter of 19891990, influenza type A(H3N2) circulated widely, causing excess morbidlty and mortality nationwide. From November through April, 19891990, hospitalized cases of pneumonia and influenza occurring among noninstitutionalized individuals 65 or more years of age were identified by 20 acute care hospitals in southern lower Michigan. These cases were group matched on age, sex, race, and zip code to randomly sampled, community-based controls from a comprehensive listing of Medicare beneficiaries residing in the study area. Self-reported data were collected from cases and controls on influenza vaccine status for the 19891990 season and on a number of other factors which could have influenced vaccination status or outcome. Questionnaires were completed by 1, 907 individuals, 449 of whom were cases, resulting in an overall response rate of 76%. A community-based influenza surveillance system was implemented to determine the timing and intensity of viral activity and influenzalike illness. Vaccine effectiveness in preventing overall pneumonia and influenza hospitalizations was estimated by logistic regression. During the 3-month period of surveillance-confirmed peak influenza type A(H3N2) circulation, vaccine effectiveness was 45% (95% confidence interval 1464,p = 0.009). However, during the 3-month period of low or absent virus activity, identical methodology and model specification resulted in an effectiveness estimate of 21% that was not statistically different from zero (p = ; 0.36). The effectiveness determined during the peak period of virus circulation is felt to be a conservative estimate, since agents other than influenza are responsible for pneumonia and influenza hospitalizations, even during times of peak influenza activity. Am J Epidemiol 1992; 136: 296307
aged; case-control studies; influenza; pneumonia; vaccination; vaccine effectiveness
3Division of Viral Diseases, Centers for Disease Control, Atlanta, GA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. C. G. Voordouw, M. C. J. M. Sturkenboom, J. P. Dieleman, T. Stijnen, J. van der Lei, and B. H. C. Stricker Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med, October 9, 2006; 166(18): 1980 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gorse, T. Z. O'Connor, S. L. Young, M. P. Habib, J. Wittes, K. M. Neuzil, and K. L. Nichol Impact of a Winter Respiratory Virus Season on Patients With COPD and Association With Influenza Vaccination. Chest, October 1, 2006; 130(4): 1109 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A Jackson, M. L Jackson, J. C Nelson, K. M Neuzil, and N. S Weiss Evidence of bias in estimates of influenza vaccine effectiveness in seniors Int. J. Epidemiol., April 1, 2006; 35(2): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Mazza, S. H. Yale, J. R. Arrowood, C. E. Reynolds, I. Glurich, P.-H. Chyou, J. G. Linneman, and K. D. Reed Efficacy of the Influenza Vaccine in Patients with Malignant Lymphoma Clin. Med. Res., November 1, 2005; 3(4): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Falsey, P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults N. Engl. J. Med., April 28, 2005; 352(17): 1749 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wongsurakiat, K. N. Maranetra, C. Wasi, U. Kositanont, W. Dejsomritrutai, and S. Charoenratanakul Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination: A Randomized Controlled Study Chest, June 1, 2004; 125(6): 2011 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Christenson, J. Hedlund, P. Lundbergh, and A. Ortqvist Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Eur. Respir. J., March 1, 2004; 23(3): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Monto Invited Commentary: Use of Selective Viral Cultures to Adjust Nonvirologic Endpoints in Studies of Influenza Vaccine Efficacy Am. J. Epidemiol., August 15, 2003; 158(4): 312 - 315. [Full Text] [PDF] |
||||
![]() |
K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Bratzler, P. M. Houck, H. Jiang, W. Nsa, C. Shook, L. Moore, and L. Red Failure to Vaccinate Medicare Inpatients: A Missed Opportunity Arch Intern Med, November 11, 2002; 162(20): 2349 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. McElhaney Guest Editorial: Influenza: A Preventable Lethal Disease J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M627 - 628. [Full Text] [PDF] |
||||
![]() |
V. H. Menec, L. MacWilliam, and F. Y. Aoki Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults Thorax, December 1, 2001; 56(90004): iv1 - 64. [Full Text] [PDF] |
||||
![]() |
E. C. Schneider, P. D. Cleary, A. M. Zaslavsky, and A. M. Epstein Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African Americans and Whites? JAMA, September 26, 2001; 286(12): 1455 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Monto, K. Hornbuckle, and S. E. Ohmit Influenza Vaccine Effectiveness among Elderly Nursing Home Residents: A Cohort Study Am. J. Epidemiol., July 15, 2001; 154(2): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ortqvist Pneumococcal vaccination: current and future issues Eur. Respir. J., July 1, 2001; 18(1): 184 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stephenson and K.G. Nicholson Influenza: vaccination and treatment Eur. Respir. J., June 1, 2001; 17(6): 1282 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Deguchi and K. Nishimura Efficacy of Influenza Vaccine in Elderly Persons in Welfare Nursing Homes: Reduction in Risks of Mortality and Morbidity During an Influenza A (H3N2) Epidemic J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(6): M391 - M394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lalezari, K. Campion, O. Keene, and C. Silagy Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients: A Pooled Analysis of Randomized Controlled Trials Arch Intern Med, January 22, 2001; 161(2): 212 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weaver, J. Krieger, J. Castorina, M. Walls, and S. Ciske Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines Arch Intern Med, January 8, 2001; 161(1): 111 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Bridges, W. W. Thompson, M. I. Meltzer, G. R. Reeve, W. J. Talamonti, N. J. Cox, H. A. Lilac, H. Hall, A. Klimov, and K. Fukuda Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial JAMA, October 4, 2000; 284(13): 1655 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Monto Preventing Influenza in Healthy Adults: The Evolving Story JAMA, October 4, 2000; 284(13): 1699 - 1701. [Full Text] [PDF] |
||||
![]() |
K. L. Nichol, L. Baken, J. Wuorenma, and A. Nelson The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease Arch Intern Med, November 8, 1999; 159(20): 2437 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Nichol, L. Baken, and A. Nelson Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease Ann Intern Med, March 2, 1999; 130(5): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens Arch Intern Med, September 14, 1998; 158(16): 1769 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Whittle, M. J. Fine, D. Z. Joyce, J. R. Lave, W. W. Young, L. J. Hough, and W. N. Kapoor Community-Acquired Pneumonia: Can It Be Defined with Claims Data? American Journal of Medical Quality, December 1, 1997; 12(4): 187 - 193. [Abstract] [PDF] |
||||
![]() |
G. A. Poland Lessons From the Influenza Vaccine Recall of 1996-1997 JAMA, September 24, 1997; 278(12): 1022 - 1023. [Abstract] [PDF] |
||||
![]() |
K. L. Nichol Booster Doses of Influenza Vaccine JAMA, December 18, 1996; 276(23): 1857 - 1857. [PDF] |
||||
![]() |
K. L. Nichol, K. L. Margolis, A. Lind, M. Murdoch, R. McFadden, M. Hauge, S. Magnan, and M. Drake Side Effects Associated With Influenza Vaccination in Healthy Working Adults: A Randomized, Placebo-Controlled Trial Arch Intern Med, July 22, 1996; 156(14): 1546 - 1550. [Abstract] [PDF] |
||||
![]() |
K. L. Nichol, A. Lind, K. L. Margolis, M. Murdoch, R. McFadden, M. Hauge, S. Magnan, and M. Drake The Effectiveness of Vaccination against Influenza in Healthy, Working Adults N. Engl. J. Med., October 5, 1995; 333(14): 889 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fiebach and W. Beckett Prevention of Respiratory Infections in Adults: Influenza and Pneumococcal Vaccines Arch Intern Med, November 28, 1994; 154(22): 2545 - 2557. [Abstract] [PDF] |
||||
![]() |
K.L. Nichol, K.L. Margolis, J. Wuorenma, and T. Von Sternberg The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community N. Engl. J. Med., September 22, 1994; 331(12): 778 - 784. [Abstract] [Full Text] |
||||
![]() |
A. S. Monto Influenza Vaccines for the Elderly N. Engl. J. Med., September 22, 1994; 331(12): 807 - 808. [Full Text] |
||||
![]() |
N. M. Bennett, B. Lewis, A. S. Doniger, K. Bell, R. Kouides, F. M. LaForce, and W. Barker A Coordinated, Communitywide Program in Monroe County, New York, to Increase Influenza Immunization Rates in the Elderly Arch Intern Med, August 8, 1994; 154(15): 1741 - 1745. [Abstract] [PDF] |
||||
![]() |
D. S. Fedson, A. Wajda, J. P. Nicol, G. W. Hammond, D. L. Kaiser, and L. L. Roos Clinical Effectiveness of Influenza Vaccination in Manitoba JAMA, October 27, 1993; 270(16): 1956 - 1961. [Abstract] [PDF] |
||||











